South Dakota Soybean (OTC:SDSYA) Stock, Quote.Headers.trade-ideas

South Dakota Soybean Processors LLC owns and operates a soybean processing plant and a soybean oil refinery. It is engaged in processing locally grown soybeans into soybean meal and soybean oil. The company offers soybean meal to resellers, feed mills, and livestock producers as livestock feed. The Company principally generates revenue from merchandising and transporting manufactured agricultural products used as ingredients in food, feed, energy, and industrial products. The Company generates most of its revenue by selling soybean meals in USA.

South Dakota Soybean Processors LLC

Shares of President Donald Trump's media company, Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) <a href="https://www.benzinga.com/general/social-media/25/01/43089193/trump-media-technology-group-shares-drop-over-2-in-overnight-trading-on-robinhood-ahead-of-first-session-post-inauguration">fell more than 3%</a> in Tuesday pre-market trading after the <a href="https://www.benzinga.com/government/regulations/25/01/43085323/trump-sworn-in-as-47th-president-declares-golden-age-of-america-begins-right-now">inauguration ceremony</a>.
This decline comes after the stock rallied nearly 15% in the past five trading sessions, and nearly 18% year-to-date.
But what does President Trump have to do with it now that he is leading the country?
Here are five things you should know about President Trump's media company.
What Is Trump Media's Market Capitalization?
At the end of market close on Friday, Trump Media's market capitalization stood at $8.68 billion.
Its trailing 12-month revenue stands at $4.1 million, while its most recent quarterly revenue – for the September 2023 quarter – stood at $1 million.
How Does It Compare To Other Social Media Companies?
Trump Media's publicly-listed competitors include other social media companies, like Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) and Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>).
Snap's trailing 12-month revenue stands at $5.17 billion, while its September quarter revenue came in at $1.4 billion.
On the other hand, Reddit's trailing 12-month revenue stands at $1.12 billion, while its September quarter revenue came in at $348.4 million.
What Do Analysts Have To Say About DJT Stock?
According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> and FactSet, there are no brokerages covering the DJT stock yet.
What Is President Trump's Stake In The Company?
President Trump transferred his approximately 59% stake in Trump Media to a revocable trust headed by his son, Donald Trump Jr., in December.
Who Are The Other Stakeholders In The DJT Stock?
Vanguard Group and BlackRock are two prominent institutional shareholders of the DJT stock – their holdings stood at 1.48% and 1.23%, respectively, at the end of the September quarter.
Overall, institutions hold 7.02% of the shares of Trump Media.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43073327/official-trump-memecoin-jumps-over-260-ahead-of-president-elects-white-house-inauguration-market-cap-reaches-whopping-4-billion-within-8-hours-of-launch">&#8216;Official Trump&#8217; Memecoin Jumps Over 260% Ahead Of President-Elect&#8217;s White House Inauguration: Market Cap Reaches Whopping $4 Billion Within 8 Hours Of Launch</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

News

Social Media

Politics

Markets

Tech

RDDT

SNAP

DJT Stock Drops 3% In Tuesday Premarket, A Day After Inauguration — Key Details About Trump's Media Company

Morgan Stanley analyst Alex Straton upgrades Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) from Equal-Weight to Overweight and raises the price target from $41 to $63.

Upgrades

Price Target

Analyst Ratings

URBN

Morgan Stanley Upgrades Urban Outfitters to Overweight, Raises Price Target to $63

As of January 21, 2025, the remaining principal balance of the Term Loan B, after these recent paydowns, was approximately $47 million.

Tutor Perini Says It Prepaid An Additional $75M Of Its Term Loan B Debt

Health Care

General

REVB

Revelation Biosciences Begins PRIME Phase 1b Clinical Study In Patients With Stage 3 and 4 Chronic Kidney Disease

"As anticipated, our digital divisions had a very strong fourth quarter, as Townsquare Interactive returned to year-over-year revenue growth, and Digital Advertising net revenue accelerated to year-over-year growth rates in excess of +15%, helped by national digital advertising returning to revenue growth together with ongoing strength in our digital programmatic business," commented Bill Wilson, Chief Executive Officer of Townsquare Media, Inc.

Guidance

Townsquare Media Expects Q4 Net Revenue Of $117M - $119M, Est $116.413M

First Quarter 2025 Outlook &amp; Guidance
‧Wafer Shipments: Will remain flat
‧ASP in USD: Will decrease by mid-single digit %
‧Gross Profit Margin: Will be higher than 25% with 0121 earthquake impact
‧Capacity Utilization: approximately 70%
‧2025 CAPEX: US$1.8 billion

United Microelectronics Expects Q1 Wafer Shipments To Be Flat, ASP Decline By Mid-Single-Digit, Gross Margin Above 25%, 2025 Capex Of $1.8B

As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to<a href="https://pro.benzinga.com/"> Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">BridgeBio Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>)</h3>
<ul>
<li>On Nov. 22, the FDA approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization.. The company's stock surged around 28% over the past month and has a <a href="https://www.benzinga.com/quote/BBIO">52-week high of $41.04</a>.</li>
<li>RSI Value: 71.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BBIO Price Action: Shares of BridgeBio Pharma fell 0.9% to close at $33.79 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)</h3>
<ul>
<li>On Jan. 15, Intuitive Surgical reported strong preliminary fourth-quarter results. "We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes," said Gary Guthart, CEO of Intuitive Surgical. The company's stock gained around 9% over the past five days and <a href="https://www.benzinga.com/quote/ISRG">has a 52-week high</a> of $597.68.</li>
<li>RSI Value: 72.6</li>
<li>ISRG Price Action: Shares of Intuitive Surgical gained 1.5% to close at $592.64 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Boston Scientific Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>)</h3>
<ul>
<li>On Jan. 8, Boston Scientific agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease. The company's stock gained around 11% over the past month and has a <a href="https://www.benzinga.com/quote/BSX">52-week high</a> of $99.14.</li>
<li>RSI Value: 75.3</li>
<li>BSX Price Action: Shares of Boston Scientific gained 0.5% to close at $98.66 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Intra-Cellular Therapies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>)</h3>
<ul>
<li>On Jan. 13, Johnson &amp; Johnson entered into a definitive agreement to acquire all outstanding shares of Intra-Cellular Therapies for $132 per share in cash in a deal that values the company at approximately $14.6 billion. The company's stock jumped around 51% over the past month and has a 52-week high is $128.00.</li>
<li>RSI Value: 85.6</li>
<li>ITCI Price Action: Shares of Intra-Cellular Therapies fell 0.05% to close at $126.20 on Friday. </li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43054647/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-with-over-9-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 9% Dividend Yields</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Trading Ideas

BBIO

ISRG

ITCI

Top 4 Health Care Stocks You May Want To Dump In Q1

"We are pleased to pre-announce our fourth quarter and full year 2024 estimated results that are directly in-line with the expectations and guidance we had previously outlined on our third quarter earnings call," the company said.

Townsquare Media Expects Full Year Net Revenue Of $450M - $452M, Within Guidance Range Of $448M - $452M; Est $449.58M

<a href="https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026590.pdf" title="https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026590.pdf">https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026590.pdf</a>

Insider Trades

Nancy Pelosi Reported Purchase of 50 Jan 2026 $20 Call Options In Tempus AI On January 14

XCharge, Hertz Partner To Upgrade EV Charging Offerings At US Airport Rental Facilities

Under the terms of the agreement, NewGen will acquire the technology for US$5 million, to be satisfied through a combination of US$750,000 in cash and the issuance of 2,500,000 ordinary shares (as may be adjusted for any reverse stock split carried out by the Company prior to Completion) at a deemed value of US$1.70 per share. The US$5 million purchase price, which has been approved by NewGen's board of directors, is supported by an independent third party valuation. This transaction structure, which is expected to boost the Company's shareholders' equity by US$4.25 million at the time of Completion, is expected to optimize the Company's capital allocation while adding significant technological capabilities to its service portfolio. Under the terms of the agreement, NewGen will assume the existing licensing agreements associated with MicroSort, which should create an immediate additional revenue stream through license fees from current users.

NIVF

NewGenIvf Agreed To Acquire MicroSort,, A Proprietary Sperm-sorting Technology That Enhances The Company's Capabilities In Providing Assisted Reproductive Services, For $5M

Earnings

Earnings Misses

United Microelectronics Q4 2024 GAAP EPADS $0.10 Misses $0.15 Estimate, Sales $1.840B Miss $1.871B Estimate

Buybacks

IMOS

Semiconductor Test Service Prover ChipMOS Approves $350M Share Buy Back

Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.75 by 1.33 percent. The company reported quarterly Adjusted sales of $113.64 million which beat the analyst consensus estimate of $109.61 million by 3.68 percent.&nbsp;

Earnings Beats

PEBO

Peoples Bancorp Q4 2024 GAAP EPS $0.76 Beats $0.75 Estimate, Adjusted Sales $113.64M Beat $109.61M Estimate

Sports

NIPG

Digital Entertainment Firm NIP Partners With Abu Dhabi Investment Office To Boost Abu Dhabi's Esports Industry

Morgan Stanley analyst Alex Poon upgrades Tencent Music Enter Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) from Equal-Weight to Overweight and maintains the price target from $13 to $13.

Morgan Stanley Upgrades Tencent Music Enter Gr to Overweight, Maintains Price Target to $13

Morgan Stanley analyst Joseph Moore upgrades Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) from Equal-Weight to Overweight and raises the price target from $90 to $106.

QRVO

Morgan Stanley Upgrades Qorvo to Overweight, Raises Price Target to $106

Keefe, Bruyette &amp; Woods analyst David Konrad maintains Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) with a Market Perform and raises the price target from $53 to $56.

Keefe, Bruyette & Woods Maintains Market Perform on Citizens Financial Group, Raises Price Target to $56

Keefe, Bruyette &amp; Woods analyst David Konrad maintains Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Outperform and raises the price target from $55 to $57.

Keefe, Bruyette & Woods Maintains Outperform on Truist Finl, Raises Price Target to $57

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains WaFd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFD#NASDAQ">WAFD</a>) with a Market Perform and lowers the price target from $42 to $34.

Comments

South Dakota Soybean

South Dakota Soybean (SDSYA) Forecast

South Dakota Soybean (OTC:SDSYA) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga